Cargando…
High MICB expression as a biomarker for good prognosis of colorectal cancer
INTRODUCTION: Major histocompatibility complex (MHC) plays an important role in colorectal cancer (CRC) immunity. However, the function of MHC class I chain-related B (MICB) molecule is not very clear. In this study, we explored the prognostic effect of MICB in colorectal cancer. MATERIAL AND METHOD...
Autores principales: | Feng, Qingyang, Yu, Shanchao, Mao, Yihao, Ji, Meiling, Wei, Ye, He, Guodong, Chang, Wenju, Zhu, Dexiang, Ren, Li, Xu, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230058/ https://www.ncbi.nlm.nih.gov/pubmed/32306128 http://dx.doi.org/10.1007/s00432-020-03159-0 |
Ejemplares similares
-
Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
por: Mao, Yihao, et al.
Publicado: (2018) -
The immune phenotypes and different immune escape mechanisms in colorectal cancer
por: Mao, Yihao, et al.
Publicado: (2022) -
No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver
Metastasis (CRLM) Patients: Incidence and Prognosis
por: Chang, Jiang, et al.
Publicado: (2022) -
Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018) -
Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis
por: Zheng, Peng, et al.
Publicado: (2018)